Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P079: Increased faecal proteolytic activity in pouchitis patients mediates epithelial barrier disruption through activation of protease-activated receptor-2

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Hoffman*1, I. M. Carrol2, H. Tulchinski3,4, I. Borovok5, I. Dotan6

1Tel Aviv medical Center, Digestive and liver Disease Research Center, Tel Aviv, Israel, 2University of North Carolina, Center for Gastrointestinal Biology and Disease, School of Medicine, Chapel Hill, USA, 3Tel Aviv Medical Center, Division of Surgery Colorectal Unit, Tel Aviv, Israel, 4Tel-Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel, 5Tel-Aviv University, Department of Molecular and Microbiology and Biotechnology, Tel Aviv, Israel, 6Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel

P080: Thioguanine nucleotide cut-off levels to predict leucopoenia should be considered differently based on NUDT15 R139C genotypes in Chinese Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

X. Zhu1, K. Chao2, H. Zheng1, P. Hu2, M. Huang1, X. Gao*2, X. Wang1

1Sun Yat-sen University, Guangzhou, China, 2The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

P081: Effect of bile acid on lymphocyte migration in the small intestine

ECCO '19 Copenhagen

Year: 2019
Authors:

N. Shibuya*1, M. Higashiyama1, S. Nishii1, A. Mizoguchi1, K. Inaba1, N. Sugihara1, Y. Hanawa1, A. Wada1, K. Horiuchi1, H. Furuhashi1, C. Kurihara1, H. Hozumi1, Y. Okada1, C. Watanabe1, S. Komoto1, K. Tomita1, S. Nagao1, M. Saruta2, R. Hokari1

1National Defense Medical College, Internal Medicine, Tokorozawa, Japan, 2Jikei University School of Medicine, Internal Medicine, Tokyo, Japan

P082: Xenobiotic nuclear receptors: linking bile acid signalling to alterations in CYP3A4 metabolism in Crohn's disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Wilson*1, A. Almousa2, R. Rose3, W. Teft2, R. Kim1

1Western University, Medicine, London, Canada, 2Western University, Physiology and Pharmacology, London, Canada, 3Western University, Epidemiology and Biostatistics, London, Canada

P083: The transcriptomic signature of IL-23-treated lamina propria mononuclear cells is significantly enriched for genes in the Th17 pathway and is enriched in active UC

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Digby-Bell1, P. Pavlidis1, U. Niazi2, Z. Kassam1, N. Prescott3, E. Perucha1, M. Saqi2, N. Powell1

1King's College London, Centre for Inflammation and Cancer Immunology (CIBCI), London, UK, 2King's College London, NIHR Biomedical Research Center, London, UK, 3King's College London, Department of Medical and Molecular Genetics, London, UK

P084: Clinical response to Ustekinumab in Crohn’s disease is linked to a dose-dependent reduction of T follicular helper cells

ECCO '19 Copenhagen

Year: 2019
Authors:

A-M. Globig*1,2, N. P. Sommer1, A. K. Thomann3, W. Reindl3, R. Schreiner4, M. Hofmann1, C. Schempp5, R. Thimme1, P. Hasselblatt1

1Medical Center – University of Freiburg, Department of Medicine II, Freiburg, Germany, 2Faculty of Medicine, University of Freiburg, Berta-Ottenstein-Programme, Freiburg, Germany, 3Medical Faculty Mannheim, Heidelberg University, Department of Medicine II, Mannheim, Germany, 4Limbach Group, Heidelberg, Germany, 5Medical Center – University of Freiburg, Department of Dermatology, Freiburg, Germany

P085: Crohn’s disease patients under combined therapy with Azathioprine and Infliximab present persistent inflammation together with a counter regulatory response during clinical disease remission

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Duarte-Silva1,2, R. S. Parra*3, M. R. Feitosa3, O. Féres3, J. J. Ribeiro da Rocha3, C. R. d1, B. Cardoso1

1School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil, Department of Clinical Analysis, Toxicology and Food Science, Ribeirão Preto, SP, Brazil, 2Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil, Department of Immunology and Biochemistry, Ribeirão Preto, Brazil, 3Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil, Surgery and Anatomy, Ribeirão Preto, SP, Brazil

P086: Eukaryotic microbial dysbiosis in treatment-naïve patients with newly diagnosed Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Goren*1,2, L. Reshef3, L. Godny1, K. Rabinowitz1, I. Dotan1,2, H. Yanai1,2

1Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel, 2Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel, 3Tel Aviv University, Department of Molecular Microbiology and Biotechnology, Tel Aviv, Israel

P087: Urinary formate and glycine are associated with treatment response in patients treated with antibiotics for pouchitis

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Segal*1, M. Sarafian2, J. I. Serrano Contreras2, A. Pechlivanis2, L. Braz1,2, Y. Siaw3, S. Clark1,2, E. Holmes2, A. Hart1,2

1St Marks Hospital, Gastroenterology, Harrow, UK, 2Imperial College London, London, UK, 3Hillingdon Hospital, Gastroenterology, Hillingdon, UK

P088: Transcriptome landscape of protein-coding genes and long noncoding RNAs in the colon and blood of DSS-induced mouse model of Acute ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Yarani*1, O. Palasca2,3, N. Tsankova Doncheva2,3, C. Anthon3,4, B. Pilecki5, T. Litman6, U. Holmskov5, L. J. Jensen2,3, J. Gorodkin3,4, F. Pociot1,7,8

1Type 1 Diabetes Biology, Department of Clinical Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark, 2Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark, 3Center for non-coding RNA in Technology and Health, University of Copenhagen, Copenhagen, Denmark, 4Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark, 5Department of Cancer and Inflammation Research, Institute of Molecular Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark, 6Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark, 7Copenhagen Diabetes Research Center, Department of Pediatrics, Herlev University Hospital, Herlev, Denmark, 8Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

P089: Extensive characterisation of cellular sources of IL-22BP in inflammatory bowel diseases indicates that T cells do not express IL-22BP

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Fantou*1,2, A. Abidi1, L. Delbos1, J. Podevin3, A. Jarry4, M. Heslan1, J. Martin1,2, A. Bourreille5,6, R. Josien1,2

1Centre de Recherche en Transplantation et Immunologie UMR 1064, Inserm, Université de Nantes, CHU Nantes, 44000 Nantes, France, 2Laboratoire d'Immunologie, CHU Nantes, 44000 Nantes, France, 3Clinique de Chirurgie Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif (IMAD), CHU Nantes, 44000 Nantes, France, 4CRCINA, INSERM, Université d'Angers, Université de Nantes, 44000 Nantes, France, 5Institut des Maladies de l’Appareil Digestif (IMAD), CHU Nantes, 44000 Nantes, France, 6UMR 1235, Neuropathies entériques et pathologies digestives, Université de Nantes, 44000 Nantes, France

P090: Exposure to high fat diet early in life impacts colitis severity in adult mice

ECCO '19 Copenhagen

Year: 2019
Authors:

Z. Al Nabhani*1, S. Dulauroy1, E. Lécuyer1, G. Eberl1

1Insitut Pasteur, Immunology, Paris, France

P091: Increased paracellular permeability in colonic biopsies from patients with ulcerative colitis in remission compared with patients with irritable bowel syndrome

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Katinios*1, S. A. Walter1, M. Vicario2, A. M. González-Castro2, J. D. Söderholm3, H. Hjortswang1, Å. V. Keita4

1Linköping University, Department of Gastroenterology, Linköping, Sweden, 2Vall d'Hebron Institut de Recerca, Digestive Diseases Research Unit, Barcelona, Spain, 3Linköping University, Department of Clinical and Experimental Medicine and Department of Surgery, Linköping, Sweden, 4Linköping University, Department of Clinical and Experimental Medicine, Linköping, Sweden

P092: Circulating classical monocytes and intestinal macrophages exhibit reduced response to IL-10 in IBD

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Hoti*1, N. McCarthy1, E. Giles1, I. Ayada1, P. Harrow1, H. Gordon1, A. Stagg1, J. Lindsay1

1Blizard Institute, Centre of Immunobiology, London, UK

P093: CD4 T-cell transcriptome analysis at baseline predicts clinical remission to anti-TNF agents in ulcerative colitis (UC)

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Subramanian*1, L. Rainbow2, M. Gemmell2, R. Hough3, S. Haldenby2, A. Gureviciute1, M. Lofthouse1, K. Martin1, C. Probert1

1Royal Liverpool University Hospital, Liverpool, UK, 2University of Liverpool, Center for genomics research, Liverpool, UK, 3Institute of Translational medicine, Department of Biostatistics, Liverpool, UK

P094: Polyphenolic extract from Chilean berry attenuates intestinal damage and improves clinical indicators in an animal model of Crohn's disease

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Ortiz*1, J-M. García-Montes2, F. Argüelles-Arias3, M. Illanes1, M. Guerra Veloz3, M. Escoriza-Rodríguez1, M. De Miguel1

1University of Seville, Normal and Pathological Cytology and Histology, Seville, Spain, 2University of Seville, Medicine, Seville, Spain, 3Virgen Macarena Hospital, Gastroenterology unit, Seville, Spain

P095: Association between tissue oncostatin M expression and infliximab response in corticosteroid refractory acute severe ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

J. O'Connell1, P. McDonagh1, N. Clarke2, A. Buckley2, C. Dunne1,3, K. Hartery1,3, J. Larkin4, F. MacCarthy3,5, P. McCormack4, S. McKiernan1,3, B. Mehigan4, C. Muldoon6, C. Ryan6, J. O'Sullivan2, D. Kevans1,3

1St James's Hospital, Department of Gastroenterology, Dublin, Ireland, 2Trinity College Dublin, Dept of Surgery, Dublin, Ireland, 3INITIative, Investigator Network Inflammatory bowel disease Therapy in Ireland, Dublin, Ireland, 4St James Hospital, Surgery, Dublin, Ireland, 5St James's Hospital, Gastroenterology, Dublin, Ireland, 6St James Hospital, Pathology, Dublin, Ireland

P096: The anti-inflammatory effects of niclosamide on cytokines produced by PBMCs derived from IBD patients

ECCO '19 Copenhagen

Year: 2019
Authors:

U. N. Shivaji*1,2, L. Jeffery1, N. Batis3, M. Iacucci1,2, S. Ghosh1,2

1National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Immunology and Immunotherapy, Birmingham, UK, 2Institute of Translational Medicine, Gastroenterology, Birmingham, UK, 3Institute of Cancer and Genomics Sciences, University of Birmingham, Birmingham, UK

P097: Intestinal barrier dysfunction in association with fibrosis during experimental acute and chronic colitis in mice

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Breugelmans*1, J. De Man1, B. De Winter1, A. Smet1

1University of Antwerp, Laboratory of Experimental Medicine and Pediatrics, Antwerp, Belgium

P098: Role of serum lysol oxidase like 2 in Crohn's disease and modulation to biological treatment

ECCO '19 Copenhagen

Year: 2019
Authors:

M. J. Garcia Garcia*1, A. Garcia Blanco2, B. Castro Senosiain1, M. Pascual Mato1, C. Del Pozo Calzada1, J. Crespo Garcia1, M. Rivero Tirado1

1Marques De Valdecilla Universitary Hospital, Gastroenterology, Santander, Spain, 2Biotechnology and Biomedicine Institute of Cantabria (IBBTEC), Santander, Spain